Delivery Order W9114F26DA005-W9114F26FA027
Award Date 1/2/26
Potential Completion Date 2/28/26
Potential Value $3.4K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Roche Diagnostics Corporation received a $200,000 delivery order from the Defense Health Agency for chemistry cost-per-reportable-result testing services, with a completion date of June 30, 2024. The award was issued on December 31, 2023, without a set-aside designation under open competition. This delivery order is a child contract stemming from Roche's established General Services Administration Schedule contract under the Critical Analyzers, Laboratory (FSS-66-III) schedule, which enables the...
- The Defense Health Agency awarded a $2.21M delivery order to Roche Diagnostics Corporation for chemistry and immunoassay testing services, effective October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract represents a child order under a larger vehicle and carries no set-aside designation, allowing Roche to compete openly in the federal marketplace. The work will be performed at Fort Sam Houston in San Antonio, Texas, a major military medical facility....
- The Defense Health Agency has awarded a delivery order valued at $2.19M to Roche Diagnostics Corporation for core laboratory chemistry testing services through September 30, 2025. This firm fixed-price delivery order, which was awarded on October 1, 2024, will be performed at Fort Sam Houston in San Antonio, Texas, supporting the military healthcare system's diagnostic testing capabilities. The award carries no set-aside designation, indicating it was competed openly in the federal...
- Roche Diagnostics Corporation has been awarded a delivery order valued at $1.18M by the Defense Health Agency for cost-per-reportable-result clinical chemistry analyzer services and reagents/consumables at Naval Hospital Camp Pendleton and Naval Hospital Bremerton. This firm fixed-price delivery order, awarded July 1, 2024, extends through May 14, 2026, and represents a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The contract...
- The Defense Health Agency awarded a delivery order to Roche Diagnostics Corporation for cost-per-reportable-results (CPRR) diagnostic testing services with a ceiling value of $1.06 million and a completion date of September 30, 2026. This contract, issued without set-aside designation, represents a child order under an existing indefinite delivery vehicle and will be performed in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis,...
- The Defense Health Agency (DHA) awarded a delivery order to Roche Diagnostics Corporation for the provision of Roche test reagents in Fiscal Year 2025. This delivery order, designated as Option III, covers the period from October 1, 2024, through September 30, 2025, with a ceiling value of $295,532.69 under a firm fixed-price contract type. The award was made on October 1, 2024, with performance taking place in Castleton, Indiana. No set-aside designation was applied to this contract award. This...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, has been awarded a delivery order valued at $722,715.31 by the Defense Health Agency for an Automated Core Lab. The order is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. The work will be performed in Castleton, Indiana, and represents a child contract—indicating it derives from a larger contract vehicle, likely one of Roche's...
- The Defense Health Agency (DOD) awarded a $482,006.00 delivery order contract to Roche Diagnostics Corporation under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) master contract for CPRR Chemistry and Immunoassay services. The contract has a period of performance starting May 1, 2022 through April 1, 2023 and utilizes a firm fixed price payment structure. The place of performance will be Roche Diagnostics Corporation's facility located in Castleton, Indiana. Roche...
- The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1.32 million firm fixed price blanket purchase agreement (BPA) call contract for monthly drop shipment of chemical monitoring services. Under this contract, Roche will provide routine delivery of chemistry testing supplies to medical treatment facilities within the DHA network located in Bethesda, Maryland. As the prime, Roche will be responsible for fulfillment through the end of February 2024 in support of the Agency's...
- Roche Diagnostics Corporation received a $3.62 million delivery order from the Defense Health Agency on December 1, 2022, for clinical chemistry and immunoassay analyzers with performance extending through September 30, 2027. This firm fixed-price contract, awarded without set-aside designation, represents a child order under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III) and leverages Roche's established relationship with the Defense Health Agency for diagnostic laboratory...